Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Page 1
Impact of the COVID-19 pandemic on the number and short-term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018-2021.
Takemura Y, Endo H, Hibi T, Nakano Y, Seishima R, Takeuchi M, Yamamoto H, Maeda H, Hanazaki K, Taketomi A, Kakeji Y, Seto Y, Ueno H, Mori M, Kitagawa Y. Takemura Y, et al. Among authors: hibi t. Hepatol Res. 2024 Feb 3. doi: 10.1111/hepr.14014. Online ahead of print. Hepatol Res. 2024. PMID: 38308614
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
Naganuma M, Nakamura N, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Kobayashi T, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Takagi T, Omori T, Tahara T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. J Gastroenterol. 2024 Apr;59(4):302-314. doi: 10.1007/s00535-024-02079-x. Epub 2024 Jan 26. J Gastroenterol. 2024. PMID: 38277006
We also investigated whether the reduction rate in patient-reported outcome 2 (PRO2) on day 3 could predict short-term prognosis. RESULTS: Eighty-five severe hospitalized patients were selected. ...
We also investigated whether the reduction rate in patient-reported outcome 2 (PRO2) on day 3 could predict short-term prognosis. RES …
Impact of COVID-19 pandemic on short-term outcomes after low anterior resection in patients with rectal cancer: Analysis of data from the Japanese National Clinical Database.
Seishima R, Endo H, Hibi T, Takeuchi M, Nakano Y, Yamamoto H, Miyata H, Maeda H, Hanazaki K, Taketomi A, Kakeji Y, Seto Y, Ueno H, Mori M, Kitagawa Y. Seishima R, et al. Among authors: hibi t. Ann Gastroenterol Surg. 2023 Aug 16;8(1):107-113. doi: 10.1002/ags3.12732. eCollection 2024 Jan. Ann Gastroenterol Surg. 2023. PMID: 38250675 Free PMC article.
AIM: The Coronavirus Disease 2019 (COVID-19) pandemic affected the allocation of various medical resources to several areas, including intensive care units (ICUs). However, currently, its impact on the short-term postoperative outcomes of gastrointestinal cancer surgeries …
AIM: The Coronavirus Disease 2019 (COVID-19) pandemic affected the allocation of various medical resources to several areas, including inten …
CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10.
Li L, Kanemitsu K, Ohnishi K, Yamada R, Yano H, Fujiwara Y, Miyamoto Y, Mikami Y, Hibi T, Baba H, Komohara Y. Li L, et al. Among authors: hibi t. Cancer Genomics Proteomics. 2024 Jan-Feb;21(1):54-64. doi: 10.21873/cgp.20429. Cancer Genomics Proteomics. 2024. PMID: 38151286 Free PMC article.
RESULTS: Analysis of the TCGA database revealed that elevated CXCL10 expression in CRC tissues correlates with improved long-term survival and is inversely associated with lymph node infiltration and metastasis. ...
RESULTS: Analysis of the TCGA database revealed that elevated CXCL10 expression in CRC tissues correlates with improved long-term sur …
Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis.
Naganuma M, Kobayashi T, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Abe T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. J Gastroenterol. 2023 Dec;58(12):1198-1210. doi: 10.1007/s00535-023-02048-w. Epub 2023 Oct 13. J Gastroenterol. 2023. PMID: 37831183
BACKGROUND: This multicenter observational cohort study aimed to evaluate the utilization and short-term efficacy of advanced therapy (AT) in hospitalized patients with acute severe ulcerative colitis (ASUC). ...
BACKGROUND: This multicenter observational cohort study aimed to evaluate the utilization and short-term efficacy of advanced therapy …
Feasible living donor liver transplantation for patients on chronic hemodialysis: a multicenter study in East Asian countries.
Furukawa K, Lee KW, Shimata K, Ito T, Toshima T, Akamatsu N, Hibi T, Hong SK, Kim JM, Hatano E, Yoshizumi T, Ikegmi T, Suh KS. Furukawa K, et al. Among authors: hibi t. Surg Today. 2024 May;54(5):471-477. doi: 10.1007/s00595-023-02751-4. Epub 2023 Sep 24. Surg Today. 2024. PMID: 37742325
The characteristics of donors and recipients and the short and long-term outcomes were analyzed. RESULTS: Between 2001 and 2021, 45 patients on HD underwent LDLT and 11 of these patients also underwent kidney transplantation (KT). ...
The characteristics of donors and recipients and the short and long-term outcomes were analyzed. RESULTS: Between 2001 and 2021, 45 p …
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.
Takeuchi T, Nishikawa K, Yamada F, Morita A, Ohtsuki M, Suzuki Y, Watanabe M, Yamanaka H, Hibi T. Takeuchi T, et al. Among authors: hibi t. Drug Saf. 2023 Oct;46(10):991-1005. doi: 10.1007/s40264-023-01340-1. Epub 2023 Sep 12. Drug Saf. 2023. PMID: 37700154 Free PMC article.
OBJECTIVE: We performed an integrated analysis of final data from three post-marketing studies to provide long-term safety and efficacy data of CT-P13 in a real-world clinical setting. ...With CT-P13 therapy, disease activity parameters decreased similarly in all four dise …
OBJECTIVE: We performed an integrated analysis of final data from three post-marketing studies to provide long-term safety and effica …
Outcome After Intestinal Transplantation From Living Versus Deceased Donors: A Propensity-matched Cohort Analysis of the International Intestinal Transplant Registry.
Ceulemans LJ, Dubois A, Clarysse M, Canovai E, Venick R, Mazariegos G, Vanuytsel T, Hibi T, Avitzur Y, Hind J, Horslen S, Gondolesi G, Benedetti E, Gruessner R, Pirenne J. Ceulemans LJ, et al. Among authors: hibi t. Ann Surg. 2023 Nov 1;278(5):807-814. doi: 10.1097/SLA.0000000000006045. Epub 2023 Jul 27. Ann Surg. 2023. PMID: 37497671 Free PMC article.
OBJECTIVE: To describe the worldwide experience with living donation (LD) in intestinal transplantation (ITx) and compare short-term and long-term outcomes to a propensity-matched cohort of deceased donors. ...
OBJECTIVE: To describe the worldwide experience with living donation (LD) in intestinal transplantation (ITx) and compare short-term …
Analysis of the short-term outcomes after esophagectomy for esophageal cancer during the COVID-19 pandemic using data from a nationwide Japanese database.
Takeuchi M, Endo H, Hibi T, Seishima R, Nakano Y, Yamamoto H, Miyata H, Maeda H, Hanazaki K, Taketomi A, Kakeji Y, Seto Y, Ueno H, Mori M, Kitagawa Y. Takeuchi M, et al. Among authors: hibi t. Esophagus. 2023 Oct;20(4):617-625. doi: 10.1007/s10388-023-01017-9. Epub 2023 Jun 22. Esophagus. 2023. PMID: 37347341
We investigated the change in medical resource, such as the intensive care unit use, and short-term outcomes after esophagectomy during the pandemic. METHODS: Data of patients who underwent esophagectomy for esophageal cancer registered in the National Clinical Database (N …
We investigated the change in medical resource, such as the intensive care unit use, and short-term outcomes after esophagectomy duri …
Surgical and Oncological Outcomes of Salvage Hepatectomy for Locally Recurrent Hepatocellular Carcinoma after Locoregional Therapy: A Single-Institution Experience.
Minagawa T, Itano O, Kitago M, Abe Y, Yagi H, Hibi T, Shinoda M, Ojima H, Sakamoto M, Kitagawa Y. Minagawa T, et al. Among authors: hibi t. Cancers (Basel). 2023 Apr 16;15(8):2320. doi: 10.3390/cancers15082320. Cancers (Basel). 2023. PMID: 37190248 Free PMC article.
Perioperative morbidities were significantly more frequently observed with recurrent HCC after locoregional therapies (p = 0.048). Long-term outcomes of recurrent HCC after locoregional therapies were worse than those after hepatectomy, though there was no prognostic diffe …
Perioperative morbidities were significantly more frequently observed with recurrent HCC after locoregional therapies (p = 0.048). Long-t …
101 results